Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation

BACKGROUND: Methotrexate is an important chemotherapeutic drug widely known as an inhibitor of dihydrofolate reductase (DHFR) which inhibits the reduction of folic acid. DHFR-mediated effects are apparently responsible for its primary antineoplastic action. However, other non-DHFR-mediated effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sramek, Martin, Neradil, Jakub, Sterba, Jaroslav, Veselska, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770555/
https://www.ncbi.nlm.nih.gov/pubmed/26929741
http://dx.doi.org/10.1186/s12935-016-0289-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770555/
https://www.ncbi.nlm.nih.gov/pubmed/26929741
http://dx.doi.org/10.1186/s12935-016-0289-2

Ejemplares similares